Acta clinica Croatica, Vol. 46 No. 2, 2007.
Stručni rad
Choroidal Neovascularization in Age-Related Macular Degeneration Treated with Photodynamic Therapy and Intravitreal Triamcinolone Acetonide
Romano Vrabec
Zoran Vatavuk
Goran Benčić
Ivan Čima
Ognjen Zrinšćak
Zdravko Mandić
Sažetak
The aim of the study was to show the effect of combined photodynamic therapy and intravitreal injection of triamcinolone acetonide in the treatment of choroidal neovascularization due to age-related macular degeneration. This retrospective, nonrandomized study included 20 patients with predominantly classic choroidal neovascularization due to age-related macular degeneration with no prior treatment. At baseline, all patients underwent ophthalmologic examination. Fluorescein angiography and optical coherent tomography were performed and analyzed. Triamcinolone acetonide, 4 mg, was intravitreally applied at 24-48 hours after standard photodynamic therapy. Follow up was scheduled at 3, 6 and 9 months. After 9 months, visual acuity improved in four, remained unchanged in 14 and decreased in two patients. In all patients, complete closure of choroidal neovascularization occurred after 9 months. At that time, a decrease in the central foveal thickness was also recorded in all patients. Combined photodynamic therapy and intravitreal injection of triamcinolone acetonide is a safe method in the treatment of choroidal neovascularization due to age-related macular degeneration, and leads to complete closure of choroidal neovascularization. To prove these promising results, a carefully designed, randomized, controlled study in a larger group of patients is needed.
Ključne riječi
Macular degeneration complications; Macular degeneration therapy; Choroidal neovascularization etiology; Choroidal neovascularization drug therapy; Photochemotherapy
Hrčak ID:
13622
URI
Datum izdavanja:
30.6.2007.
Posjeta: 1.950 *